Ability of baclofen in reducing alcohol intake and withdrawal severity: I - Preclinical evidence

Alcoholism: Clinical and Experimental Research

Volumn 24, Issue 1, 2000, Pages 58-66

  Colombo, Giancarlo ^a,b   Agabio, Roberta ^b   Carai, Mauro A M ^b,c   Lobina, Carla ^b,c   Pani, Marialaura ^b   Reali, Roberta ^c   Addolorato, Giovanni ^d   Gessa, Gian Luigi ^a,c  

^a CNR   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Neuroscienze PharmaNess Scarl   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Baclofen; Ethanol Withdrawal Syndrome; GABA(B) receptor; Sardinian Alcohol Preferring (sP) Rats; Voluntary Ethanol Intake

Indexed keywords

4 HYDROXYBUTYRIC ACID; BACLOFEN;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFICACY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RIGIDITY; SCORING SYSTEM; TREMOR; VOCALIZATION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0033968854     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000374-200001000-00010     Document Type: Article

References (95)

1. Addolorato G, Balducci G, Capristo E, Attilia ML, Taggi F, Gasbarrini G, Ceccanti M (1999) Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcoholism Clin Exp Res 23:1596-1604.
2. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G (2000) Ability of baclofen in reducing alcohol craving and intake: II - Preliminary clinical evidence. Alcoholism Clin Exp Res 24:67-71.
3. Addolorato G, Castelli E, Stefanini GF, Casella G, Caputo F, Marsigli L, Bernardi M, Gasbarrini G, GHB Study Group (1996) An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. Alcohol Alcohol 31:341-345.
4. Addolorato G, Cibin M, Capristo E, Beghè F, Gessa GL, Stefanini GF, Gasbarrini G (1998) Maintaining abstinence from alcohol with gamma-hydroxybutyric acid. Lancet 351:38.
5. Agabio R, Colombo G, Loche A, Lobina C, Pani ML, Reali R, Gessa GL (1998) Gamma-hydroxybutyric acid (GHB) reducing effect on ethanol intake: Evidence in favour of a substitution mechanism. Alcohol Alcohol 33:465-474.
6. Ågmo A, Pruneda R, Guzmán M, Gutiérrez M (1991) GABAergic drugs and conflict behavior in the rat: Lack of similarities with the actions of benzodiazepines. Naunyn Schmiedebergs Arch Pharmacol 344:314-322.
7. Andrews N, File SE (1993a) Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur J Pharmacol 235:109-112.
8. Andrews N, File SE (1993b) Increased 5-HT release mediates the anxiogenic during benzodiazepine withdrawal: A review of supporting neurochemical and behavioural evidence. Psychopharmacology 112:21-25.
9. Benedito MAC, Leite JR (1981) Baclofen an anticonvulsant in experimental models of convulsion. Exp Neurol 72:346-351.
10. Breslow MF, Fankhauser MP, Potter RL, Meredith KE, Misiaszek J, Hope DG Jr (1989) Role of gamma-aminobutyric in antipanic drug efficacy. Am J Psychiat 146:353-356.
11. B agonists on sensitization to the locomotor stimulant effects of ethanol in DBA/2 J mice. Psychopharmacology 141:197-205.
12. Buckland C, Mellanby J, Gray JA (1986) The effects of compounds related to gamma-aminobutyrate and benzodiazepine receptors on behavioural responses to anxiogenic stimuli in the rat: Extinction and successive discrimination. Psychopharmacology 88:285-295.
13. Campbell UC, Lac ST, Carroll ME (1999) Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 143:209-214.
14. Chester JA, Cunningham CL (1999) Baclofen alters ethanol-stimulated activity but not conditioned place preference or taste aversion in mice. Pharmacol Biochem Behav 63:325-331.
15. Colombo G (1997) Ethanol drinking behaviour in Sardinian alcohol-preferring rats. Alcohol Alcohol 32:443-453.
16. Colombo G, Agabio R, Lobina C, Reali R, Fadda F, Gessa GL (1995a) Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: Occurrence within narrow dose ranges. Physiol Behav 57:105-111.
17. B receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. Physiol Behav 64:293-302.
18. Colombo G, Agabio R, Lobina C, Reali R, Vacca G, Gessa GL (1998b) Stimulation of locomotor activity by voluntarily consumed ethanol in Sardinian alcohol-preferring rats. Eur J Pharmacol 357:109-113.
19. Colombo G, Agabio R, Lobina C, Reali R, Zocchi A, Fadda F, Gessa GL (1995b) Sardinian alcohol-preferring rats: A genetic animal model of anxiety. Physiol Behav 57:1181-1185.
20. Cott J, Carlsson A, Engel J, Lindqvist M (1976) Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn Schmiedebergs Arch Pharmacol 295:203-209.
21. Cottrell GA, Robertson HA (1987) Baclofen exacerbates epileptic myoclonus in kindled rats. Neuropharmacology 26:645-648.
22. B receptors in excitation and inhibition of thalamocortical cells. Trends Neurosci 14:16-21.
23. Dalvi A, Rodgers RJ (1996) GABAergic influence on plus-maze behaviour in mice. Psychopharmacology 128:380-397.
24. Daoust M, Saligaut C, Lhuintre JP, Moore N, Flipo JL, Boismare F (1987) GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats. Alcohol 4:469-472.
25. Da Prada M, Keller HH (1976) Baclofen and gamma-hydroxybutyrate: Similar effects on cerebral dopamine neurones. Life Sci 19:1253-1264.
26. B receptors in the basal forebrain selectively impairs working memory in rats in the double Y-maze. Brain Res 641:29-38.
27. B-receptor activation alters the firing pattern of dopamine neurons in the substantia nigra. Synapse 15:229-238.
28. B-receptors. Naunyn Schmiedebergs Arch Pharmacol 348:491-497.
29. Erden BF, Ozdemirci S, Yildiran G, Utkan T, Gacar N, Ulak G (1999) Dextromethorphan attenuates ethanol withdrawal syndrome in rats. Pharmacol Biochem Behav 62:537-541.
30. Fadda F, Colombo G, Mosca E, Gessa GL (1989) Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats. Alcohol Alcohol 24:447-451.
31. File SE, Zharkovsky A, Gulati K (1991) Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat. Neuropharmacology 30:183-190.
32. Follesa P, Ticku MK (1996) Chronic ethanol-mediated up-regulation of the N-methyl-D-aspartate receptor polypeptide subunits in mouse cortical neurons in culture. J Biol Chem 271:13297-13299.
33. B receptors on hippocampal CA1 and CA3 pyramidal neurons to ethanol. Brain Res 735:239-248.
34. Frye GD, McCown TJ, Breese GR, Peterson SL (1986) GABAergic modulation of inferior colliculus excitability: Role in ethanol withdrawal audiogenic seizures. J Pharmacol Exp Ther 237:478-485.
35. Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD, Fadda F, Gessa GL (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet ii:787-789.
36. Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL (1992) Gamma-hydroxybutyric acid in the treatment of alcohol dependence: A double-blind study. Alcohol Clin Exp Res 16:673-676.
37. Gessa GL, Agabio R, Carai MAM, Lobina C, Pani M, Reali R, Colombo G (1999) Mechanism of the anti-alcohol effect of gamma-hydroxybutyric acid (GHB). Alcohol, in press.
38. Gessa GL, Crabai F, Vargiu L, Spano PF (1968) Selective increase of brain dopamine induced by gamma-hydroxybutyrate: Study of the mechanism of action. J Neurochem 15:377-381.
39. Grant KA, Snell LD, Rogawski MA, Thurkauf A, Tabakoff B (1992) Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J Pharmacol Exp Ther 260: 1017-1022.
40. Grant KA, Valverius P, Hudspith M, Tabakoff B (1990) Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol 176:289-296.
41. Grove-White IG, Kelman GR (1971) Effect of methohexitone, diazepam and sodium 4-hydroxybutyrate on short-term memory. Br J Anaesth 43:113-116.
42. Gulya K, Grant KA, Valverius P, Hoffman PL, Tabakoff B (1991) Brain regional specificity and time-course of change in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res 547:129-134.
43. B binding that is blocked by valproate and ethosuximide. J Pharmacol Exp Ther 281:753-760.
44. Hudgson P, Weighman D (1971) Baclofen in the treatment of spasticity. Br Med J 4:15-17.
45. B receptors in mediating the effects of ethanol in mice. Psychopharmacology 111:219-224.
46. B ligands on alcohol withdrawal in mice. Pharmacol Biochem Behav 49:561-566.
47. Iorio KR, Reinlib L, Tabakoff B, Hoffman PL (1992) Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function. Mol Pharmacol 41:1142-1148.
48. B receptor in cultured cerebellar granule cells. J Neurochem 65:75-83.
49. June HL, Williams JA, Cason CR, Devaraju S, Lin M, Murphy JM, Lewis MJ, Lumeng L, Li T-K (1995) Low doses of gamma-hydroxybutyric acid (GHB) attenuate ethanol intake in alcohol-preferring (P) rats. Alcohol Clin Exp Res (Suppl. 2) 19:14A.
50. B receptors. Eur J Pharmacol 163:285-290.
51. Kasture SB, Mandhane SN, Chopde CT (1996) Baclofen-induced catatonia: Modification by serotonergic agents. Neuropharmacology 35:595-598.
52. Ketelaars CEJ, Bollen EL, Rigter H, Bruinvels J (1988) GABA-B receptors activation and conflict behaviour. Life Sci 42:933-942.
53. Koob GF (1992) Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
54. Kršiak M, Novakova D, Paclt I, Ostrovskaya RU (1974) Effect of sodium hydroxybutyrate on behavior of mice after prolonged isolation. Bull Exp Biol Med 77:288-291.
55. Laborit H (1973) Gamma-hydroxybutyrate, succinic semialdehyde and sleep. Prog Neurobiol 1:257-274.
56. Lal H, Harris CM, Benjamin D, Springfield AC, Bhadra S, Emmett-Oglesby MW (1988) Characterization of a pentylentetrazol-like interoceptive stimulus produced by ethanol withdrawal. J Pharmacol Exp Ther 247:508-518.
57. Liljequist S (1991) The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. Eur J Pharmacol 192:197-198.
58. Ling W, Shoptaw S, Majewska D (1998) Baclofen as a cocaine anti-craving medication: A preliminary clinical study. Neuropsychopharmacology 18:403-404.
59. Majchrowicz E (1975) Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia (Berlin) 43:245-254.
60. B receptor agonist, dose-dependently impairs spatial learning in rats. Pharmacol Biochem Behav 53:303-308.
61. B receptor and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol 46:423-462.
62. B transmission, in CA1 neurons during withdrawal in vivo chronic ethanol treatment. J Pharmacol Exp Ther 274:1035-1041.
63. Morrisett RA, Rezvani AH, Overstreet D, Janowsky DS, Wilson WA, Swartzwelder HS (1990) MK-801 potently inhibits alcohol withdrawal seizures in rats. Eur J Pharmacol 176:103-105.
64. Mott DD, Bragdon AC, Lewis DV, Wilson WA (1989) Baclofen has a proepileptic effect in the rat dentate gyrus. J Pharmacol Exp Ther 249:721-725.
65. Navarro JF, Martín-López, Manzaneque JM, Pedraza MC, Dávila G (1996) Dose-dependent effect of gammahydroxybutyrate (GHB) on catalepsy in male mice. Med Sci Res 24:603-604.
66. Nimmerrichter AA, Beckmann E, Gazsó E, Mader R, Marx B, Plech A, Puchinger H, Saletu M, Lesch OM (1997) Double blind controlled trial of GHB in two dosages and chlormethiazole in the treatment of alcohol withdrawal syndrome. Alcohol Clin Exp Res 21(Suppl):32A.
67. B-receptor antagonist, CGP 35348, antagonizes gamma-hydroxybutyrate-and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice. J Neural Transm 103:1255-1263.
68. Quintero S, Henney S, Lawson P, Mellandy J, Gray JA (1985) The effects of compounds related to gamma-aminobutyrate and benzodiazepine receptors on behavioural responses to anxiogenic stimuli in the rat: Punished barpressing. Psychopharmacology 85:244-251.
69. Roberts DSC, Andrews MM (1997) Baclofen suppression of cocaine self-administration: Demonstration using a discrete trials procedure. Psychopharmacology 131:271-277.
70. Roberts DSC, Andrews MM, Vickers GJ (1996) Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15: 417-423.
71. A receptors in the rat amygdala. Pharmacol Biochem Behav 52:701-706.
72. A and NMDA receptor function in the rat brain. Alcohol Clin Exp Res 17:115-123.
73. Schmidt-Mutter C, Pain L, Sandner G, Gobaille S, Maitre M (1998) The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil. Eur J Pharmacol 342:21-27.
74. Shephard RA, Toal L, Leslie J (1990) Effects of agonist and antagonists at the GABA/benzodiazepine receptor on conditioned suppression in rats. Pharmacol Biochem Behav 36:39-43.
75. Shephard RA, Wedlock P, Wilson NE (1992) Direct evidence for mediation of an anticonflict effect of baclofen by GABAb receptors. Pharmacol Biochem Behav 41:651-653.
76. B agonist baclofen modifies cocaine self-administration in rats. Behav Pharmacol 9:195-206.
77. B agonist baclofen on the temporal and structural characteristics of ethanol intake. Alcohol 17:231-240.
78. Smith BR, Robidoux J, Amit Z (1992) GABAergic involvement in the acquisition of voluntary ethanol intake in laboratory rats. Alcohol Alcohol 27:227-231.
79. B and gamma-hydroxybutyric acid receptor antagonists. Pharmacol Biochem Behav 53:73-79.
80. B) receptor in rat brain. Biochem Pharmacol 52:1235-1243.
81. Snell LD, Tabakoff B, Hoffman P (1993) Radioligand binding to the N-methyl-D-aspartate receptor/ionophore complex: Alteration by ethanol in vitro and by chronic in vivo ethanol ingestion. Brain Res 602:91-98.
82. Stackman RW, Walsh TJ (1994) Baclofen produces dose-related working memory impairments after intraseptal injection. Behav Neural Biol 61:181-185.
83. Tarika JS, Winger G (1980) The effects of ethanol, phenobarbital, and baclofen on ethanol withdrawal in the rhesus monkey. Psychopharmacology 70:201-208.
84. Ticku MK (1990) Alcohol and GABA-benzodiazepine receptor function. Ann Med 22:241-246.
85. B receptor activation in the dorsal raphe nucleus modulates ethanol intake in Wistar rats. Behav Pharmacol 7:85-93.
86. Trevisan L, Fitzgerald LW, Brose N, Gasic GP, Heinemann SP, Duman RS, Nestler EJ (1994) Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampus. J Neurochem 62:1635-1638.
87. Valverius P, Crabbe JC, Hoffman PL, Tabakoff B (1990) NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures. Eur J Pharmacol 184:185-189.
88. B antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis. Naunyn Schmiedebergs Arch Pharmacol 343:173-178.
89. B receptor-mediated hyperpolarization. Neuroscience 66: 133-141.
90. B and NMDA receptor agonists on medial forebrain bundle self-stimulation. Behav Brain Res 70:31-36.
91. Winter JC (1981) The stimulus properties of gamma-hydroxybutyrate. Psychopharmacology 73:371-375.
92. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
93. Yoshida M, Yokoo H, Tanaka T, Emoto H, Tanaka M (1994) Opposite changes in the mesolimbic metabolism in the nerve terminal and cell body sites induced by locally infused in the rat. Brain Res 636:111-114.
94. Xi Z-X, Stein EA (1999) Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther 290:1369-1374.
95. B receptors. Eur J Pharmacol 212:291-294.